dangers of taking glp 1 The promise and peril GLP-1 agonists: What we do (and don't) know as of August 2024 Clinical Recommendations to Manage Gastrointestinal

Contact Newsweek editors on this story: Jason Lemon and Anthony Murray

Hoegberg, L., Shepherd, G., Wood, D., Johnson, J., Hoffman, R., Caravati, E., Chan, W., Smith, S., Olson, K., & Gosselin, S

The modern diet, which typically contains up to 15 times more omega-6 PUFAs than omega-3 PUFAs, along with a common deficiency of DHA in the brain, results in the production of large amounts of lipid mediators derived from LA and AA, contributing to chronic inflammation and oxidative stress implicated in cardiovascular, metabolic, inflammatory, and neuropsychiatric disorders (18, 50, 5759)

until at least 2032, when the first main patent for the drug, held by Novo Nordisk,expires